Literature DB >> 21142409

Cerebral venous thrombosis due to essential thrombocythemia and worsened by heparin-induced thrombocytopenia and thrombosis.

Sebastien Richard1, Julien Perrin, Karine Lavandier, Jean-Christophe Lacour, Xavier Ducrocq.   

Abstract

This case describes the medical history of a 61-year-old woman treated for cerebral venous thrombosis (CVT) leading to diagnosis of essential thrombocythemia (ET). During treatment with unfractionated heparin, after initial improvement of clinical state, signs of cerebral hypertension reappeared. Although the platelet count decreased, heparin-induced thrombocytopenia (HIT) was only suspected 2 days later when it dropped below the standard 150 × 10(9) L(-1) threshold. HIT diagnosis was confirmed by the presence of anti-PF4/heparin IgG. This late finding was the cause of the extension of CVT with worsening of cerebral hypertension necessitating decompressive craniectomy. Elevated basal platelet count due to ET can delay diagnosis and treatment of HIT. In this case, physicians should be more attentive to platelet count variations rather than thrombocytopenia threshold.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21142409     DOI: 10.3109/09537104.2010.527399

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  8 in total

1.  Heparin-induced thrombocytopenia associated with polycythemia vera during the treatment of acute coronary syndrome.

Authors:  Takashi Yoshizane; Makoto Iwama; Takahiro Ueno; Maya Ishiguro; Yoshiaki Goto; Koji Ono; Masazumi Arai; Toshiyuki Noda
Journal:  J Cardiol Cases       Date:  2016-04-28

2.  Cerebral venous thrombosis due to cryptogenic organising pneumopathy with antiphospholipid syndrome worsened by heparin-induced thrombocytopenia.

Authors:  J Hsieh; I Kuzmanovic; M I Vargas; I Momjian-Mayor
Journal:  BMJ Case Rep       Date:  2013-07-09

3.  HIT in the head: a systematic review of cerebral venous sinus thrombosis in classical and autoimmune heparin-induced thrombocytopenia.

Authors:  Megan M J Bauman; Ryan M Naylor; Eelco F Wijdicks
Journal:  J Thromb Thrombolysis       Date:  2021-06-05       Impact factor: 2.300

Review 4.  Heparin-Induced Thrombocytopenia: A Focus on Thrombosis.

Authors:  Gowthami M Arepally; Anand Padmanabhan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-12-03       Impact factor: 8.311

5.  Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera.

Authors:  Sara C Meyer; Eva Steinmann; Thomas Lehmann; Patricia Muesser; Jakob R Passweg; Radek C Skoda; Dimitrios A Tsakiris
Journal:  Biomed Res Int       Date:  2017-06-18       Impact factor: 3.411

6.  Cyclosporine-A-Induced Intracranial Thrombotic Complications: Systematic Review and Cases Report.

Authors:  Si-Ying Song; Zhong-Ao Wang; Yu-Chuan Ding; Xun-Ming Ji; Ran Meng
Journal:  Front Neurol       Date:  2021-02-11       Impact factor: 4.003

7.  Heparin-Induced Thrombocytopenia in a Patient with Essential Thrombocythemia: A Case Based Update.

Authors:  Edva Noel; Naeem Abbas; Yevegeniy Skaradinskiy; Zwi Schreiber
Journal:  Case Rep Hematol       Date:  2015-10-22

8.  What cardiologists should know about essential thrombocythemia and acute myocardial infarction: report of two cases and advanced heart failure therapies considerations.

Authors:  Marie-Camille Soucy-Giguère; Pierre Yves Turgeon; Mario Sénéchal
Journal:  Int Med Case Rep J       Date:  2019-08-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.